World’s largest independent cancer research charity, advancing science and patient-focused care since 2002.
Recent reporting shows targeted drugs, immunotherapies and refined radiochemotherapy are prolonging life for cancer patients. Trials indicate higher survival in younger groups and expanding use of genomic profiling. New therapies are pairing with existing treatments to push back relapse and increase quality of life, though access and long-term outcomes vary.
[Synopsis here]
A QMUL-led Lancet study shows the HPV vaccine has dramatically reduced cervical cancer deaths among 20-24-year-olds in England from 2020–2024. England also sees an 80% fall in deaths in 2015–2019 for this age group. Yet uptake gaps threaten future gains as vaccination rates fall in parts of the country.
AstraZeneca has announced that Wainua, its gene-silencer drug for transthyretin-mediated amyloid cardiomyopathy, did not meet its primary endpoint in a phase 3 trial. The news triggers a sharp stock drop and prompts investors to rethink the company’s long-term growth targets and the strength of its pipeline.
A UK NHS study indicates focal therapy provides durable long‑term cancer control for many prostate cancer patients, with just two of 3,477 men dying from prostate cancer a decade after treatment and lower side‑effects. The government is expanding access to more centres.
International researchers find inherited genetics influence how cancers evolve after DNA damage, affecting tumour growth and mutation patterns. The Edinburgh-led work, published in Nature, underlines implications for screening, diagnosis and personalised treatment across populations.
Cambridge and ICR researchers show NICE criteria miss up to 95% of women under 50 who will develop breast cancer within 10 years. A new model called Boadicea identifies eight times as many high-risk women, prompting calls for review and investment to implement multifactorial risk assessment across the NHS.
A Scottish athlete’s plea for a national brain cancer lead has intensified calls for a faster, more coordinated national cancer plan. Across the UK, brain tumours remain a leading cause of death for under-40s, with funding and access to treatment under scrutiny.
Lucy Davis has disclosed a Stage 4 breast cancer diagnosis that has metastasised to her bones. She states the cancer is incurable and that chemotherapy is no longer an option. She will continue living as fully as possible while seeking privacy for her family.